Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0393754 (
HSA
)
2,996
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Carbon nanotubes (CNTs) with unique and outstanding properties were expected to revolutionize various aspects of the biomedical sector. Interaction studies of proteins with functionalized CNTs would shed light on their toxicological aspects upon entering the human body. Hyperchromicity of the UV-Visible spectra and declining fluorescence potential of
HSA
on interaction with CNTs suggested ground state complex to exist between them. Synchronous and 3D spectral features of CNT-
HSA
system proposed their possible binding site to occur nearby Trp and Tyr residues. FTIR and FT-Raman spectra showed a shift in the amide band region that proportionate the possible alteration to occur in the alpha-helical structures. CD far and near spectra showed loss of alpha-helical structures and shift in the Trp position of the polypeptide backbone. CNT's UV and FTIR band showed shift on interaction with
HSA
, which conveys the possible aggregation of CNTs in the presence of protein. The promoting role of CNTs against
HSA
fibril formation has been confirmed by spectroscopic and microscopic evaluations. Secondary conformational changes, besides the existence of increased beta-sheet structures of
HSA
amyloid fibrils, remain similar to the amyloid behavior of
Prion protein
. Hence,
HSA
fibril-CNT interface predominates the possible mechanism for several amyloid-related disorders concerning their toxic accumulations in the body.
...
PMID:Prion like behavior of HSA-hydroxylated MWCNT interface. 2731 39